Related references
Note: Only part of the references are listed.Evolution of Systemic Therapy for Hepatocellular Carcinoma
Richard S. Finn et al.
HEPATOLOGY (2021)
Local and Regional Therapies for Hepatocellular Carcinoma
Roman Kloeckner et al.
HEPATOLOGY (2021)
Hepatocellular carcinoma, novel therapies on the horizon
Imane El Dika et al.
CHINESE CLINICAL ONCOLOGY (2021)
3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application
Chao An et al.
BMC CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Role of locoregional therapies in the wake of systemic therapy
Daniel H. Palmer et al.
JOURNAL OF HEPATOLOGY (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Computed tomography-guided radiofrequency ablation combined with transarterial embolization assisted by a three-dimensional visualization ablation planning system for hepatocellular carcinoma in challenging locations: a preliminary study
Zhi-mei Huang et al.
ABDOMINAL RADIOLOGY (2020)
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
Stephen P. Hack et al.
FUTURE ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
Chihua Fang et al.
HEPATOLOGY INTERNATIONAL (2020)
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
Di-Yang Xie et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Thomas Yau et al.
JAMA ONCOLOGY (2020)
Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
Alison L. Raybould et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
Immunotherapy for advanced hepatocellular carcinoma, where are we?
Li Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis
Chen Shuanggang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI): A novel treatment for patients with advanced hepatocellular carcinoma
Min Meng et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma
Leonardo G. da Fonseca et al.
CLINICS IN LIVER DISEASE (2020)
Locoregional Therapies for Hepatocellular Carcinoma What Has Changed in the Past Ten Years?
Anjana A. Pillai et al.
CLINICS IN LIVER DISEASE (2020)
TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma
Xin Li et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study
Xin Li et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Masatoshi Kudo et al.
GUT (2020)
Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
Christoph Roderburg et al.
HEPATIC ONCOLOGY (2020)
Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options
Shima Ghavimi et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Hye Won Lee et al.
IMMUNE NETWORK (2020)
Systemic Treatment for Advanced Hepatocellular Carcinoma
Mohamed Bouattour et al.
LIVER CANCER (2019)
Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy
Wooil Kim et al.
ABDOMINAL RADIOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma
Zhenwei Peng et al.
RADIOLOGY (2019)
Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
Jianming Xu et al.
CLINICAL CANCER RESEARCH (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3-7 cm
Yashwant Patidar et al.
INDIAN JOURNAL OF RADIOLOGY AND IMAGING (2019)
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
Priti S. Hegde et al.
SEMINARS IN CANCER BIOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
Shuichiro Shiina et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou et al.
LIVER CANCER (2018)
Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma
Rusi Zhang et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2018)
Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Lin Li et al.
BMC GASTROENTEROLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
Takuji Okusaka et al.
ESMO OPEN (2018)
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Jie Yu et al.
GUT (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
Konstantinos Katsanos et al.
PLOS ONE (2017)
Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional visualization operative treatment planning system and percutaneous transhepatic cholangial drainage with intraductal chilled saline perfusion for larger hepatic hilum hepatocellular (D ≥ 3 cm): preliminary results
Jie Yu et al.
ONCOTARGET (2017)
The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
Fei-Xiang Wu et al.
BMC CANCER (2017)
Immunity, tolerance and autoimmunity in the liver: A comprehensive review
Derek G. Doherty
JOURNAL OF AUTOIMMUNITY (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
Jean-Francois Geschwind et al.
RADIOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Targeting the tumor vasculature to enhance T cell activity
Evripidis Lanitis et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2015)
Watershed Hepatocellular Carcinomas: The Risk of Incomplete Response following Transhepatic Arterial Chemoembolization
Nishita Kothary et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
Kichang Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma
Xuesong Yao et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma
Loukia S. Poulou et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Transarterial Chemoembolization vs. Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma 2 cm or Smaller
Jong Woo Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
R. Lencioni et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria-A 10-Year Update
Muneeb Ahmed et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
Thermal ablation of tumours: biological mechanisms and advances in therapy
Katrina F. Chu et al.
NATURE REVIEWS CANCER (2014)
A Comparison of Direct Heating During Radiofrequency and Microwave Ablation in Ex Vivo Liver
Anita Andreano et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Hepatic embolotherapy in interventional oncology: Technology, techniques, and applications
J. Kritzinger et al.
CLINICAL RADIOLOGY (2013)
Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy
Lin-Feng Xu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy
Ping Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
Marta Burrel et al.
JOURNAL OF HEPATOLOGY (2012)
Lack of Response after Initial Chemoembolization for Hepatocellular Carcinoma: Does It Predict Failure of Subsequent Treatment?
Christos Georgiades et al.
RADIOLOGY (2012)
Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
Luigi Bolondi et al.
SEMINARS IN LIVER DISEASE (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Chemoembolization for Hepatocellular Carcinoma: Multivariate Analysis of Predicting Factors for Tumor Response and Survival in a 362-Patient Cohort
Hong Tao Hu et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Principles of and Advances in Percutaneous Ablation
Muneeb Ahmed et al.
RADIOLOGY (2011)
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
Antoine Bouchard-Fortier et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Systematic Review of Randomized Trials for Hepatocellular Carcinoma Treated with Percutaneous Ablation Therapies
Yun Ku Cho et al.
HEPATOLOGY (2009)
Angiogenesis in liver disease
Mercedes Fernandez et al.
JOURNAL OF HEPATOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver
N. Bhardwaj et al.
PATHOLOGY (2009)
Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization
B. Wang et al.
ACTA RADIOLOGICA (2008)
Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease
Bruno M. Strebel et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
Francis Y. Yao et al.
HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of focal heat destruction of liver tumors
M Nikfarjam et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation
P Liang et al.
RADIOLOGY (2005)
Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis
AS Wright et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: A retrospective analysis
S Katyal et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2000)
Share Paper
